Impact of pharmacist managed oral epidermal growth factor receptor inhibitors.
Ng S, Baker N, Niu F, Katzel JA, Bergere HT, Whang M, McGary E, Liu R, Le K, Hui RL.
Ng S, et al. Among authors: whang m.
J Oncol Pharm Pract. 2024 Jul 23:10781552241265891. doi: 10.1177/10781552241265891. Online ahead of print.
J Oncol Pharm Pract. 2024.
PMID: 39042924